Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.
about
How to decrease bronchopulmonary dysplasia in your neonatal intensive care unit today and "tomorrow".Antimicrobial and biophysical properties of surfactant supplemented with an antimicrobial peptide for treatment of bacterial pneumonia.Overcoming inactivation of the lung surfactant by serum proteins: a potential role for fluorocarbons?Challenges Associated with Route of Administration in Neonatal Drug Delivery.
P2860
Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Delivery and performance of su ...... to treat pulmonary disorders.
@en
Delivery and performance of su ...... to treat pulmonary disorders.
@nl
type
label
Delivery and performance of su ...... to treat pulmonary disorders.
@en
Delivery and performance of su ...... to treat pulmonary disorders.
@nl
prefLabel
Delivery and performance of su ...... to treat pulmonary disorders.
@en
Delivery and performance of su ...... to treat pulmonary disorders.
@nl
P2093
P2860
P356
P1433
P1476
Delivery and performance of su ...... to treat pulmonary disorders.
@en
P2093
Anubhav Kaviratna
Cory Berkland
Nashwa El-Gendy
Prajnaparamita Dhar
P2860
P304
P356
10.4155/TDE.13.72
P577
2013-08-01T00:00:00Z